Share this page on LinkedIn
Share This Page on Google+
Share This Page on Twitter
tell someone about this page print this page
You are here: Contents > 2013 > Volume 22 Number 1 January 2013 > MISCELLANEOUS > Regulatory T-Cell Deficiency in Rheumatic Heart Disease: A Preliminary Observational Study

Regulatory T-Cell Deficiency in Rheumatic Heart Disease: A Preliminary Observational Study

Saibal Mukhopadhyay, Saurabh Varma, Sandeep Gade, Jamal Yusuf , Vijay Trehan, Sanjay Tyagi

Department of Cardiology, G. B. Pant Hospital, New Delhi, National Institute of Pathology (ICMR), New Delhi, India

Background and aim of the study: Autoimmunity plays an essential role in the pathogenesis of rheumatic heart disease (RHD). The CD4⁺CD25⁺ T cell (Tregs) is the chief regulator of autoimmunity, and is essential for the induction and maintenance of self-tolerance and prevention of autoimmunity. To date, the levels of Tregs in RHD have not been investigated. Hence, the study aim was to monitor levels of circulating Tregs in patients with RHD, and to determine whether these differ according to the extent of valvular involvement. Methods: A total of 100 adult patients with RHD and 50 age- and gender-matched controls were studied. Patients were subdivided according to the extent of left-sided valvular involvement. Those with echocardiographic evidence only of significant mitral valve disease were enrolled in the univalvular group, while those with significant involvement of both mitral and aortic valves were allocated to the multivalvular group.

Levels of circulating Tregs were determined using flow cytometry. Results: Levels of Tregs in total lymphocytes and CD4⁺ T lymphocytes were significantly lower in RHD patients than in controls (3.55 ± 2.28% versus 5.76 ± 4.2%; p <0.001, and 14.4 ± 9.4% versus 18.6 ± 10.4%; p = 0.011, respectively). Within the study group, the proportion of Tregs to total and CD4⁺ T lymphocytes was significantly lower in patients with multivalvular than with univalvular disease (2.7 ± 1.52% versus 4.41 ± 2.58%; p = 0.001 and 11.5 ± 8.5% versus 17.4 ± 9.4%; p = 0.001, respectively). Conclusion: The present study was the first to demonstrate a significant deficiency of circulating Tregs in RHD patients; notably, the reduction was greater in patients with multivalvular than with univalvular involvement.

The Journal of Heart Valve Disease 2013;22:118-125

Regulatory T-Cell Deficiency in Rheumatic Heart Disease: A Preliminary Observational Study

Click the above hyperlink to view the article, right click (Ctrl click on a Mac) to open in a new browser window or tab.

Purchase this Article

Please click the button below to purchase this article. Single article purchases are provided at $50.00 per article. Upon clicking the button below, single article user account subscription details are requested and, upon successful payment, a single article user account is created. Single articles are availble in your account for seven days after purchase.